Measles mumps/rubella
Ended Awarded Last action
- Contract number
- SPE2DR26FX1EB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,664
Award facts
- Contract value 100% obligated
- $17,663.70 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $17,663.70 delivery order to AmerisourceBergen Drug Corp on March 11, 2026, for measles, mumps, and rubella vaccine.
The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (valued at up to $999,999,999.00 through December 2026), which supplies pharmaceutical products and medical supplies to support military healthcare programs worldwide. Place of performance is Conshohocken, PA. The order carries a firm fixed price and ultimate completion date of March 11, 2026. No set-aside applies.
Quick answers
Who was awarded contract SPE2DR26FX1EB?
SPE2DR26FX1EB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on March 11, 2026.
How much is contract SPE2DR26FX1EB worth?
The government has obligated $17,664 on SPE2DR26FX1EB.
Is contract SPE2DR26FX1EB an order under another contract?
Yes. SPE2DR26FX1EB is a delivery order under SPE2DR25D7062, an indefinite delivery contract.
Was contract SPE2DR26FX1EB competed?
The extent of competition for SPE2DR26FX1EB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award